- FDA delays Leqembi decision; Artiva raises $300M; Pharvaris prices offering🗓️ FDA delays subcutaneous Leqembi decision: Originally slated for later this month, the decision date now falls on August 24, Biogen and Eisai said. The agency asked for more information from ...Endpoints · 2mo ago↗ source
- <![CDATA[OncLive Polls Reveal Picks for Top Lung Cancer Abstracts at ASCO 2026]]><![CDATA[Lung cancer experts rank key abstracts of interest from the upcoming ASCO Annual Meeting on OncLive’s social media.]]>onclive · 2mo ago↗ source
- <![CDATA[Poll Results Highlight Breast Cancer Abstracts of Interest at ASCO 2026]]><![CDATA[Readers share their opinions on some of the most talked-about breast cancer abstracts they’re looking forward to seeing at ASCO 2026.]]>